QCLS Q/C Technologies, Inc.

0.6367USD+0.74%Mkt Cap: 5.21M $P/E: 0.24

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…

HeadlineSourceTime
Older
Health Care Roundup: Market Talk

Find insight on AstraZeneca, Q/C Technologies and more in the latest Market Talks covering the health care sector.

The Wall Street Journal